Aelis Farma
Aelis Farma43About
What does Aelis Farma do?
Aelis Farma is a clinical-stage biopharmaceutical company focused on developing novel treatments for brain and peripheral disorders by targeting the CB1 receptor. Their proprietary platform generates Signaling Specific inhibitors of the CB1 receptor (CB1-SSi), which mimic a natural brain defense mechanism to treat various neurological conditions without disrupting normal behavior. The company's lead candidates, AEF0117 and AEF0217, are in advanced clinical trials for cannabis use disorders and c…
What is Aelis Farma's revenue?
StartupHub estimates Aelis Farma's annual revenue at $2.6M (range $1.5M to $9.4M, 69% confidence), based on comparable companies in the sector.
What is Aelis Farma's valuation?
StartupHub estimates Aelis Farma's effective valuation at $32.6M (range $20.5M to $74.9M, 56% confidence), based on comparable companies in the sector.
How much funding has Aelis Farma raised?
Aelis Farma has raised a total of $54M in funding. The most recent round on record is Grant.
Where is Aelis Farma headquartered?
Aelis Farma is headquartered in Bordeaux, Nouvelle-Aquitaine, France.
When was Aelis Farma founded?
Aelis Farma was founded in 2013.
What industry does Aelis Farma operate in?
Aelis Farma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.
How many employees does Aelis Farma have?
Aelis Farma has approximately 25 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.